Has Anthony Ditomaso, MD received payments from drug or device companies?

Yes. Drug and device makers reported $215 in general payments to Anthony Ditomaso, MD across 7 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anthony Ditomaso, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anthony Ditomaso, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anthony Ditomaso, MD

Gastroenterology · Englewood, FLNPI 1407840408

Payments from drug & device makers

$215in general payments, 2019–2025

Across 7 payments — averaging $30.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Madrigal Pharmaceuticals$73
Regeneron Healthcare Solutions, Inc.$66
O&m Halyard, Inc.$24
E.r. Squibb & Sons, L.L.C.$20
Boston Scientific$16
Medtronic$15

What the payments were for

Food & beverage$19591%
Education$209%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Madrigal Pharmaceuticals	1	$73
Regeneron Healthcare Solutions, Inc.	2	$66
O&m Halyard, Inc.	1	$24
E.r. Squibb & Sons, L.L.C.	1	$20
Boston Scientific	1	$16
Medtronic	1	$15

How this compares

$215 in reported general payments places this provider in the 10th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida →

Medicare billing

Part B allowed, 2024

$337,655

Medicare patients

1,311

Services billed

2,279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XifaxanRifaximin	38	$116,542
ZenpepLipase/Protease/Amylase	11	$65,315
CreonLipase/Protease/Amylase	19	$52,450
LinzessLinaclotide	52	$41,800
ViberziEluxadoline	12	$27,995
Dexlansoprazole DrDexlansoprazole	82	$27,948
Pantoprazole Sodium	1,921	$22,926
Mesalamine	36	$14,822
Sucralfate	309	$10,493
CholestyramineCholestyramine (With Sugar)	149	$8,843
Famotidine	479	$7,470
Budesonide EcBudesonide	18	$6,888
Budesonide DrBudesonide	43	$6,472
Mesalamine ErMesalamine	11	$5,272
Omeprazole	285	$4,673

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Englewood

Howard SchwartzTavernier$38.8M
Guy NeffSarasota$17.6M
Syed LateefClermont$6.4M
Jeffrey SchneiderCoral Springs$6M
Zaid RanaMiami$5.4M
David NelsonGainesville$5.2M
Alan WeintraubTampa$4.7M
Curtis FreedlandNew Port Richey$4.5M
Paul HellsternCrystal River$4.5M
Henry LevineOrlando$3.4M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →